Medical Care

Global Anti-tumor Drug Market Research Report 2025

The global market for Anti-tumor Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry and genetic engineering have accelerated the process of drug development. The research and development of anti-tumor drugs have been into a new era.
In China, Anti-tumor Drug key players include AstraZeneca, Merck & Co., Roche, Celgene, Johnson & Johnson, etc.
United States is the largest market, followed by Japan, and Europe.
This report aims to provide a comprehensive presentation of the global market for Anti-tumor Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-tumor Drug.
The Anti-tumor Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-tumor Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-tumor Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Segment by Type
Cytotoxic Drugs
Non-cytotoxic Drugs
Segment by Application
Alkylating Agents
Anti-Metabolism Drugs
Platinum Antineoplastic Agents
Anthracycline Antitumor Drugs
Microtubule Stabilizer
Endocrine Therapy Drugs
Immunotherapy Drugs
Gene Therapy Drugs
Targeted Antineoplastic Drugs
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-tumor Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-tumor Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cytotoxic Drugs
1.2.3 Non-cytotoxic Drugs
1.3 Market by Application
1.3.1 Global Anti-tumor Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Alkylating Agents
1.3.3 Anti-Metabolism Drugs
1.3.4 Platinum Antineoplastic Agents
1.3.5 Anthracycline Antitumor Drugs
1.3.6 Microtubule Stabilizer
1.3.7 Endocrine Therapy Drugs
1.3.8 Immunotherapy Drugs
1.3.9 Gene Therapy Drugs
1.3.10 Targeted Antineoplastic Drugs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-tumor Drug Market Perspective (2020-2031)
2.2 Global Anti-tumor Drug Growth Trends by Region
2.2.1 Global Anti-tumor Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Anti-tumor Drug Historic Market Size by Region (2020-2025)
2.2.3 Anti-tumor Drug Forecasted Market Size by Region (2026-2031)
2.3 Anti-tumor Drug Market Dynamics
2.3.1 Anti-tumor Drug Industry Trends
2.3.2 Anti-tumor Drug Market Drivers
2.3.3 Anti-tumor Drug Market Challenges
2.3.4 Anti-tumor Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-tumor Drug Players by Revenue
3.1.1 Global Top Anti-tumor Drug Players by Revenue (2020-2025)
3.1.2 Global Anti-tumor Drug Revenue Market Share by Players (2020-2025)
3.2 Global Anti-tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anti-tumor Drug Revenue
3.4 Global Anti-tumor Drug Market Concentration Ratio
3.4.1 Global Anti-tumor Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-tumor Drug Revenue in 2024
3.5 Global Key Players of Anti-tumor Drug Head office and Area Served
3.6 Global Key Players of Anti-tumor Drug, Product and Application
3.7 Global Key Players of Anti-tumor Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-tumor Drug Breakdown Data by Type
4.1 Global Anti-tumor Drug Historic Market Size by Type (2020-2025)
4.2 Global Anti-tumor Drug Forecasted Market Size by Type (2026-2031)
5 Anti-tumor Drug Breakdown Data by Application
5.1 Global Anti-tumor Drug Historic Market Size by Application (2020-2025)
5.2 Global Anti-tumor Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Anti-tumor Drug Market Size (2020-2031)
6.2 North America Anti-tumor Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Anti-tumor Drug Market Size by Country (2020-2025)
6.4 North America Anti-tumor Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-tumor Drug Market Size (2020-2031)
7.2 Europe Anti-tumor Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Anti-tumor Drug Market Size by Country (2020-2025)
7.4 Europe Anti-tumor Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-tumor Drug Market Size (2020-2031)
8.2 Asia-Pacific Anti-tumor Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Anti-tumor Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Anti-tumor Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-tumor Drug Market Size (2020-2031)
9.2 Latin America Anti-tumor Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Anti-tumor Drug Market Size by Country (2020-2025)
9.4 Latin America Anti-tumor Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-tumor Drug Market Size (2020-2031)
10.2 Middle East & Africa Anti-tumor Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Anti-tumor Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Anti-tumor Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Anti-tumor Drug Introduction
11.1.4 Roche Revenue in Anti-tumor Drug Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Anti-tumor Drug Introduction
11.2.4 Novartis Revenue in Anti-tumor Drug Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Celgene
11.3.1 Celgene Company Details
11.3.2 Celgene Business Overview
11.3.3 Celgene Anti-tumor Drug Introduction
11.3.4 Celgene Revenue in Anti-tumor Drug Business (2020-2025)
11.3.5 Celgene Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Anti-tumor Drug Introduction
11.4.4 Bristol-Myers Squibb Revenue in Anti-tumor Drug Business (2020-2025)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Anti-tumor Drug Introduction
11.5.4 Amgen Revenue in Anti-tumor Drug Business (2020-2025)
11.5.5 Amgen Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Anti-tumor Drug Introduction
11.6.4 Johnson & Johnson Revenue in Anti-tumor Drug Business (2020-2025)
11.6.5 Johnson & Johnson Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Anti-tumor Drug Introduction
11.7.4 Pfizer Revenue in Anti-tumor Drug Business (2020-2025)
11.7.5 Pfizer Recent Development
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Takeda Business Overview
11.8.3 Takeda Anti-tumor Drug Introduction
11.8.4 Takeda Revenue in Anti-tumor Drug Business (2020-2025)
11.8.5 Takeda Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Details
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Anti-tumor Drug Introduction
11.9.4 Eli Lilly Revenue in Anti-tumor Drug Business (2020-2025)
11.9.5 Eli Lilly Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Anti-tumor Drug Introduction
11.10.4 AstraZeneca Revenue in Anti-tumor Drug Business (2020-2025)
11.10.5 AstraZeneca Recent Development
11.11 Astellas
11.11.1 Astellas Company Details
11.11.2 Astellas Business Overview
11.11.3 Astellas Anti-tumor Drug Introduction
11.11.4 Astellas Revenue in Anti-tumor Drug Business (2020-2025)
11.11.5 Astellas Recent Development
11.12 Merck & Co
11.12.1 Merck & Co Company Details
11.12.2 Merck & Co Business Overview
11.12.3 Merck & Co Anti-tumor Drug Introduction
11.12.4 Merck & Co Revenue in Anti-tumor Drug Business (2020-2025)
11.12.5 Merck & Co Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Anti-tumor Drug Introduction
11.13.4 Sanofi Revenue in Anti-tumor Drug Business (2020-2025)
11.13.5 Sanofi Recent Development
11.14 Bayer
11.14.1 Bayer Company Details
11.14.2 Bayer Business Overview
11.14.3 Bayer Anti-tumor Drug Introduction
11.14.4 Bayer Revenue in Anti-tumor Drug Business (2020-2025)
11.14.5 Bayer Recent Development
11.15 Biogen Idec
11.15.1 Biogen Idec Company Details
11.15.2 Biogen Idec Business Overview
11.15.3 Biogen Idec Anti-tumor Drug Introduction
11.15.4 Biogen Idec Revenue in Anti-tumor Drug Business (2020-2025)
11.15.5 Biogen Idec Recent Development
11.16 Eisai
11.16.1 Eisai Company Details
11.16.2 Eisai Business Overview
11.16.3 Eisai Anti-tumor Drug Introduction
11.16.4 Eisai Revenue in Anti-tumor Drug Business (2020-2025)
11.16.5 Eisai Recent Development
11.17 Teva
11.17.1 Teva Company Details
11.17.2 Teva Business Overview
11.17.3 Teva Anti-tumor Drug Introduction
11.17.4 Teva Revenue in Anti-tumor Drug Business (2020-2025)
11.17.5 Teva Recent Development
11.18 Otsuka
11.18.1 Otsuka Company Details
11.18.2 Otsuka Business Overview
11.18.3 Otsuka Anti-tumor Drug Introduction
11.18.4 Otsuka Revenue in Anti-tumor Drug Business (2020-2025)
11.18.5 Otsuka Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Anti-tumor Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cytotoxic Drugs
Table 3. Key Players of Non-cytotoxic Drugs
Table 4. Global Anti-tumor Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Anti-tumor Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Anti-tumor Drug Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Anti-tumor Drug Market Share by Region (2020-2025)
Table 8. Global Anti-tumor Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Anti-tumor Drug Market Share by Region (2026-2031)
Table 10. Anti-tumor Drug Market Trends
Table 11. Anti-tumor Drug Market Drivers
Table 12. Anti-tumor Drug Market Challenges
Table 13. Anti-tumor Drug Market Restraints
Table 14. Global Anti-tumor Drug Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Anti-tumor Drug Market Share by Players (2020-2025)
Table 16. Global Top Anti-tumor Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-tumor Drug as of 2024)
Table 17. Ranking of Global Top Anti-tumor Drug Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Anti-tumor Drug Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Anti-tumor Drug, Headquarters and Area Served
Table 20. Global Key Players of Anti-tumor Drug, Product and Application
Table 21. Global Key Players of Anti-tumor Drug, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-tumor Drug Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Anti-tumor Drug Revenue Market Share by Type (2020-2025)
Table 25. Global Anti-tumor Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Anti-tumor Drug Revenue Market Share by Type (2026-2031)
Table 27. Global Anti-tumor Drug Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Anti-tumor Drug Revenue Market Share by Application (2020-2025)
Table 29. Global Anti-tumor Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Anti-tumor Drug Revenue Market Share by Application (2026-2031)
Table 31. North America Anti-tumor Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Anti-tumor Drug Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Anti-tumor Drug Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Anti-tumor Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Anti-tumor Drug Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Anti-tumor Drug Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Anti-tumor Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Anti-tumor Drug Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Anti-tumor Drug Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anti-tumor Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Anti-tumor Drug Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Anti-tumor Drug Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Anti-tumor Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Anti-tumor Drug Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Anti-tumor Drug Market Size by Country (2026-2031) & (US$ Million)
Table 46. Roche Company Details
Table 47. Roche Business Overview
Table 48. Roche Anti-tumor Drug Product
Table 49. Roche Revenue in Anti-tumor Drug Business (2020-2025) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Novartis Company Details
Table 52. Novartis Business Overview
Table 53. Novartis Anti-tumor Drug Product
Table 54. Novartis Revenue in Anti-tumor Drug Business (2020-2025) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Celgene Company Details
Table 57. Celgene Business Overview
Table 58. Celgene Anti-tumor Drug Product
Table 59. Celgene Revenue in Anti-tumor Drug Business (2020-2025) & (US$ Million)
Table 60. Celgene Recent Development
Table 61. Bristol-Myers Squibb Company Details
Table 62. Bristol-Myers Squibb Business Overview
Table 63. Bristol-Myers Squibb Anti-tumor Drug Product
Table 64. Bristol-Myers Squibb Revenue in Anti-tumor Drug Business (2020-2025) & (US$ Million)
Table 65. Bristol-Myers Squibb Recent Development
Table 66. Amgen Company Details
Table 67. Amgen Business Overview
Table 68. Amgen Anti-tumor Drug Product
Table 69. Amgen Revenue in Anti-tumor Drug Business (2020-2025) & (US$ Million)
Table 70. Amgen Recent Development
Table 71. Johnson & Johnson Company Details
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Anti-tumor Drug Product
Table 74. Johnson & Johnson Revenue in Anti-tumor Drug Business (2020-2025) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Anti-tumor Drug Product
Table 79. Pfizer Revenue in Anti-tumor Drug Business (2020-2025) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Takeda Company Details
Table 82. Takeda Business Overview
Table 83. Takeda Anti-tumor Drug Product
Table 84. Takeda Revenue in Anti-tumor Drug Business (2020-2025) & (US$ Million)
Table 85. Takeda Recent Development
Table 86. Eli Lilly Company Details
Table 87. Eli Lilly Business Overview
Table 88. Eli Lilly Anti-tumor Drug Product
Table 89. Eli Lilly Revenue in Anti-tumor Drug Business (2020-2025) & (US$ Million)
Table 90. Eli Lilly Recent Development
Table 91. AstraZeneca Company Details
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Anti-tumor Drug Product
Table 94. AstraZeneca Revenue in Anti-tumor Drug Business (2020-2025) & (US$ Million)
Table 95. AstraZeneca Recent Development
Table 96. Astellas Company Details
Table 97. Astellas Business Overview
Table 98. Astellas Anti-tumor Drug Product
Table 99. Astellas Revenue in Anti-tumor Drug Business (2020-2025) & (US$ Million)
Table 100. Astellas Recent Development
Table 101. Merck & Co Company Details
Table 102. Merck & Co Business Overview
Table 103. Merck & Co Anti-tumor Drug Product
Table 104. Merck & Co Revenue in Anti-tumor Drug Business (2020-2025) & (US$ Million)
Table 105. Merck & Co Recent Development
Table 106. Sanofi Company Details
Table 107. Sanofi Business Overview
Table 108. Sanofi Anti-tumor Drug Product
Table 109. Sanofi Revenue in Anti-tumor Drug Business (2020-2025) & (US$ Million)
Table 110. Sanofi Recent Development
Table 111. Bayer Company Details
Table 112. Bayer Business Overview
Table 113. Bayer Anti-tumor Drug Product
Table 114. Bayer Revenue in Anti-tumor Drug Business (2020-2025) & (US$ Million)
Table 115. Bayer Recent Development
Table 116. Biogen Idec Company Details
Table 117. Biogen Idec Business Overview
Table 118. Biogen Idec Anti-tumor Drug Product
Table 119. Biogen Idec Revenue in Anti-tumor Drug Business (2020-2025) & (US$ Million)
Table 120. Biogen Idec Recent Development
Table 121. Eisai Company Details
Table 122. Eisai Business Overview
Table 123. Eisai Anti-tumor Drug Product
Table 124. Eisai Revenue in Anti-tumor Drug Business (2020-2025) & (US$ Million)
Table 125. Eisai Recent Development
Table 126. Teva Company Details
Table 127. Teva Business Overview
Table 128. Teva Anti-tumor Drug Product
Table 129. Teva Revenue in Anti-tumor Drug Business (2020-2025) & (US$ Million)
Table 130. Teva Recent Development
Table 131. Otsuka Company Details
Table 132. Otsuka Business Overview
Table 133. Otsuka Anti-tumor Drug Product
Table 134. Otsuka Revenue in Anti-tumor Drug Business (2020-2025) & (US$ Million)
Table 135. Otsuka Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
Table 139. Authors List of This Report


List of Figures
Figure 1. Anti-tumor Drug Picture
Figure 2. Global Anti-tumor Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-tumor Drug Market Share by Type: 2024 VS 2031
Figure 4. Cytotoxic Drugs Features
Figure 5. Non-cytotoxic Drugs Features
Figure 6. Global Anti-tumor Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Anti-tumor Drug Market Share by Application: 2024 VS 2031
Figure 8. Alkylating Agents Case Studies
Figure 9. Anti-Metabolism Drugs Case Studies
Figure 10. Platinum Antineoplastic Agents Case Studies
Figure 11. Anthracycline Antitumor Drugs Case Studies
Figure 12. Microtubule Stabilizer Case Studies
Figure 13. Endocrine Therapy Drugs Case Studies
Figure 14. Immunotherapy Drugs Case Studies
Figure 15. Gene Therapy Drugs Case Studies
Figure 16. Targeted Antineoplastic Drugs Case Studies
Figure 17. Anti-tumor Drug Report Years Considered
Figure 18. Global Anti-tumor Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Anti-tumor Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Anti-tumor Drug Market Share by Region: 2024 VS 2031
Figure 21. Global Anti-tumor Drug Market Share by Players in 2024
Figure 22. Global Top Anti-tumor Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-tumor Drug as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Anti-tumor Drug Revenue in 2024
Figure 24. North America Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Anti-tumor Drug Market Share by Country (2020-2031)
Figure 26. United States Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Anti-tumor Drug Market Share by Country (2020-2031)
Figure 30. Germany Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Anti-tumor Drug Market Share by Region (2020-2031)
Figure 38. China Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Anti-tumor Drug Market Share by Country (2020-2031)
Figure 46. Mexico Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Anti-tumor Drug Market Share by Country (2020-2031)
Figure 50. Turkey Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Anti-tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Roche Revenue Growth Rate in Anti-tumor Drug Business (2020-2025)
Figure 54. Novartis Revenue Growth Rate in Anti-tumor Drug Business (2020-2025)
Figure 55. Celgene Revenue Growth Rate in Anti-tumor Drug Business (2020-2025)
Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Anti-tumor Drug Business (2020-2025)
Figure 57. Amgen Revenue Growth Rate in Anti-tumor Drug Business (2020-2025)
Figure 58. Johnson & Johnson Revenue Growth Rate in Anti-tumor Drug Business (2020-2025)
Figure 59. Pfizer Revenue Growth Rate in Anti-tumor Drug Business (2020-2025)
Figure 60. Takeda Revenue Growth Rate in Anti-tumor Drug Business (2020-2025)
Figure 61. Eli Lilly Revenue Growth Rate in Anti-tumor Drug Business (2020-2025)
Figure 62. AstraZeneca Revenue Growth Rate in Anti-tumor Drug Business (2020-2025)
Figure 63. Astellas Revenue Growth Rate in Anti-tumor Drug Business (2020-2025)
Figure 64. Merck & Co Revenue Growth Rate in Anti-tumor Drug Business (2020-2025)
Figure 65. Sanofi Revenue Growth Rate in Anti-tumor Drug Business (2020-2025)
Figure 66. Bayer Revenue Growth Rate in Anti-tumor Drug Business (2020-2025)
Figure 67. Biogen Idec Revenue Growth Rate in Anti-tumor Drug Business (2020-2025)
Figure 68. Eisai Revenue Growth Rate in Anti-tumor Drug Business (2020-2025)
Figure 69. Teva Revenue Growth Rate in Anti-tumor Drug Business (2020-2025)
Figure 70. Otsuka Revenue Growth Rate in Anti-tumor Drug Business (2020-2025)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies